Global Generic Pharmaceuticals Market Size study & Forecast, by Type ( Simple Generics, Specialty Generics, Biosimilars), by Application ( Central Nervous System Disorders, Respiratory Diseases, Hormones & Related Diseases, Gastrointestinal Diseases, Cardiovascular Diseases, Infectious Diseases and Others), by Product (Small Molecule, Large Molecule), By Route of Administration (Oral, Injectable, Inhalable and Others), by Distribution Channel (Online Pharmacies, Hospitals Pharmacies, Retail Pharmacies)and Regional Analysis, 2023-2030
Global Generic Pharmaceuticals Market is valued at approximately USD 361.7 billion in 2022 and is anticipated to grow with a healthy growth rate of more than 8.3% over the forecast period 2022-2029. Generic pharmaceuticals are medications that are identical, or bioequivalent, to brand-name drugs in terms of dosage, safety, strength, route of administration, quality, and intended use. Generic drugs are produced after the patent for the original brand-name drug has expired. This allows other pharmaceutical companies to manufacture and sell the same medication at a lower cost because they do not need to invest in the costly research and development that is required to create a new drug. The Generic Pharmaceuticals market is expanding because of factors such as rising, increasing ANDA approval and generic product launches and government initiatives to promote the usage of generics.
The rise in the number of ANDA approvals and generic medication product launches accounts for the market growth. according to the U.S. FDA's Generic Drugs Annual report, the number of ANDA approvals increased from 948 in 2020 to 776 in 2021. Additionally, from the same source, it was reported that 100 ANDAs had been approved overall by the end of 2021. Governments have implemented programs that offer various opportunities for significant generic drug players to cut back on expenditure on pharmaceuticals. As an illustration, by using generic medications in 2021, the U.S. government saved USD 373 million on pharmaceutical costs. According to the AAM Generic Drug & Biosimilars Access & Savings Report 2021, 91% of prescriptions are filled with generic medication, which represents 18.2% of prescription drug costs. In addition, the increasing Disease Burden and Rising Geriatric Population are creating lucrative growth in the market. However, a lack of transparency about the actual price of generic drugs hampers the market growth.
The key regions considered for the Global Generic Pharmaceuticals Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America dominated the market in terms of revenue, owing to the presence of key market growth and the region's increasing disease prevalence, along with these increasing number of favorable government initiatives coupled with the rising number of product launches and demand for a generic drug is driving the market growth in the region. Whereas Asia Pacific is expected to grow with the highest CAGR during the forecast period, owing to factors such as rising geriatric and target populations, an increase in the number of collaborations for product development, geographic expansion of key players, and active participation of government and nonprofit organizations in the market space.
Major market player included in this report are:
Teva Pharmaceutical Industries Ltd.
Viatris Inc.
Novartis AG
Sun Pharmaceutical Industries Ltd.
LUPIN
AbbVie Inc. (Allergan)
AstraZeneca
Sawai Pharmaceutical Co., Ltd.
Hikma Pharmaceuticals PLC
Dr. Reddy’s Laboratories Ltd.
Recent Developments in the Market:
In January 2022, the Mark Cuban Cost Plus Drugs Company (MCCPDC) announced the launch of an online pharmacy. The pharmacy would offer around more than 100 generic drugs at a low cost to patients.
Global Generic Pharmaceuticals Market Report Scope:
Historical Data – 2020 - 2021
Base Year for Estimation – 2022
Forecast period - 2023-2030
Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered – Type, Application, Product, Application, Route of Administration, Distribution Channel, Region
Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa
Customization Scope - Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.
The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Type:
Simple Generics
Specialty Generics
Biosimilars
By Application:
Central Nervous System Disorders
Respiratory Diseases
Hormones & Related Diseases
Gastrointestinal Diseases
Cardiovascular Diseases
Infectious Diseases
Others
By Product:
Small Molecule
Large Molecule
By Route of Administration:
Oral
Injectable
Inhalable
Others
Distribution Channel:
Online Pharmacies
Hospitals Pharmacies
Retail Pharmacies
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
RoLA
Middle East & Africa
Saudi Arabia
South Africa
Rest of Middle East & Africa
The rise in the number of ANDA approvals and generic medication product launches accounts for the market growth. according to the U.S. FDA's Generic Drugs Annual report, the number of ANDA approvals increased from 948 in 2020 to 776 in 2021. Additionally, from the same source, it was reported that 100 ANDAs had been approved overall by the end of 2021. Governments have implemented programs that offer various opportunities for significant generic drug players to cut back on expenditure on pharmaceuticals. As an illustration, by using generic medications in 2021, the U.S. government saved USD 373 million on pharmaceutical costs. According to the AAM Generic Drug & Biosimilars Access & Savings Report 2021, 91% of prescriptions are filled with generic medication, which represents 18.2% of prescription drug costs. In addition, the increasing Disease Burden and Rising Geriatric Population are creating lucrative growth in the market. However, a lack of transparency about the actual price of generic drugs hampers the market growth.
The key regions considered for the Global Generic Pharmaceuticals Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America dominated the market in terms of revenue, owing to the presence of key market growth and the region's increasing disease prevalence, along with these increasing number of favorable government initiatives coupled with the rising number of product launches and demand for a generic drug is driving the market growth in the region. Whereas Asia Pacific is expected to grow with the highest CAGR during the forecast period, owing to factors such as rising geriatric and target populations, an increase in the number of collaborations for product development, geographic expansion of key players, and active participation of government and nonprofit organizations in the market space.
Major market player included in this report are:
Teva Pharmaceutical Industries Ltd.
Viatris Inc.
Novartis AG
Sun Pharmaceutical Industries Ltd.
LUPIN
AbbVie Inc. (Allergan)
AstraZeneca
Sawai Pharmaceutical Co., Ltd.
Hikma Pharmaceuticals PLC
Dr. Reddy’s Laboratories Ltd.
Recent Developments in the Market:
In January 2022, the Mark Cuban Cost Plus Drugs Company (MCCPDC) announced the launch of an online pharmacy. The pharmacy would offer around more than 100 generic drugs at a low cost to patients.
Global Generic Pharmaceuticals Market Report Scope:
Historical Data – 2020 - 2021
Base Year for Estimation – 2022
Forecast period - 2023-2030
Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered – Type, Application, Product, Application, Route of Administration, Distribution Channel, Region
Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa
Customization Scope - Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.
The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Type:
Simple Generics
Specialty Generics
Biosimilars
By Application:
Central Nervous System Disorders
Respiratory Diseases
Hormones & Related Diseases
Gastrointestinal Diseases
Cardiovascular Diseases
Infectious Diseases
Others
By Product:
Small Molecule
Large Molecule
By Route of Administration:
Oral
Injectable
Inhalable
Others
Distribution Channel:
Online Pharmacies
Hospitals Pharmacies
Retail Pharmacies
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
RoLA
Middle East & Africa
Saudi Arabia
South Africa
Rest of Middle East & Africa
CHAPTER 1. EXECUTIVE SUMMARY
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
1.2.1. Generic Pharmaceuticals Market, by Region, 2020-2030 (USD Billion)
1.2.2. Generic Pharmaceuticals Market, by Type, 2020-2030 (USD Billion)
1.2.3. Generic Pharmaceuticals Market, by Application, 2020-2030 (USD Billion)
1.2.4. Generic Pharmaceuticals Market, by Product, 2020-2030 (USD Billion)
1.2.5. Generic Pharmaceuticals Market, by Route of Administration, 2020-2030 (USD Billion)
1.2.6. Generic Pharmaceuticals Market, by Distribution Channel, 2020-2030 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
CHAPTER 2. GLOBAL GENERIC PHARMACEUTICALS MARKET DEFINITION AND SCOPE
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Industry Evolution
2.2.2. Scope of the Study
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
CHAPTER 3. GLOBAL GENERIC PHARMACEUTICALS MARKET DYNAMICS
3.1. Generic Pharmaceuticals Market Impact Analysis (2020-2030)
3.1.1. Market Drivers
3.1.1.1. Increasing ANDA approval and Generic Product Launches
3.1.1.2. Government initiatives to promote usage of generics
3.1.2. Market Challenges
3.1.2.1. High Cost of Generic Pharmaceuticals
3.1.2.2. Pricing issues
3.1.3. Market Opportunities
3.1.3.1. Increasing Disease Burden
3.1.3.2. Rising Geriatric Population
CHAPTER 4. GLOBAL GENERIC PHARMACEUTICALS MARKET INDUSTRY ANALYSIS
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Porter’s 5 Force Impact Analysis
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.3.5. Environmental
4.3.6. Legal
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. COVID-19 Impact Analysis
4.7. Disruptive Trends
4.8. Industry Expert Perspective
4.9. Analyst Recommendation & Conclusion
CHAPTER 5. GLOBAL GENERIC PHARMACEUTICALS MARKET, BY TYPE
5.1. Market Snapshot
5.2. Global Generic Pharmaceuticals Market by Type, Performance - Potential Analysis
5.3. Global Generic Pharmaceuticals Market Estimates & Forecasts by Type 2020-2030 (USD Billion)
5.4. Generic Pharmaceuticals Market, Sub Segment Analysis
5.4.1. Simple Generics
5.4.2. Specialty Generics
5.4.3. Biosimilars
CHAPTER 6. GLOBAL GENERIC PHARMACEUTICALS MARKET, BY APPLICATION
6.1. Market Snapshot
6.2. Global Generic Pharmaceuticals Market by Application, Performance - Potential Analysis
6.3. Global Generic Pharmaceuticals Market Estimates & Forecasts by Application 2020-2030 (USD Billion)
6.4. Generic Pharmaceuticals Market, Sub Segment Analysis
6.4.1. Central Nervous System Disorders
6.4.2. Respiratory Diseases
6.4.3. Hormones & Related Diseases
6.4.4. Gastrointestinal Diseases
6.4.5. Cardiovascular Diseases
6.4.6. Infectious Diseases
6.4.7. Others
CHAPTER 7. GLOBAL GENERIC PHARMACEUTICALS MARKET, BY PRODUCT
7.1. Market Snapshot
7.2. Global Generic Pharmaceuticals Market by Product, Performance - Potential Analysis
7.3. Global Generic Pharmaceuticals Market Estimates & Forecasts by Product 2020-2030 (USD Billion)
7.4. Generic Pharmaceuticals Market, Sub Segment Analysis
7.4.1. Small Molecule
7.4.2. Large Molecule
CHAPTER 8. GLOBAL GENERIC PHARMACEUTICALS MARKET, BY ROUTE OF ADMINISTRATION
8.1. Market Snapshot
8.2. Global Generic Pharmaceuticals Market by Route of Administration, Performance - Potential Analysis
8.3. Global Generic Pharmaceuticals Market Estimates & Forecasts by Route of Administration 2020-2030 (USD Billion)
8.4. Generic Pharmaceuticals Market, Sub Segment Analysis
8.4.1. Oral
8.4.2. Injectable
8.4.3. Inhalable
8.4.4. Others
CHAPTER 9. GLOBAL GENERIC PHARMACEUTICALS MARKET, BY DISTRIBUTION CHANNEL
9.1. Market Snapshot
9.2. Global Generic Pharmaceuticals Market by Distribution Channel, Performance - Potential Analysis
9.3. Global Generic Pharmaceuticals Market Estimates & Forecasts by Distribution channel 2020-2030 (USD Billion)
9.4. Generic Pharmaceuticals Market, Sub Segment Analysis
9.4.1. Online Pharmacies
9.4.2. Retail Pharmacies
9.4.3. Hospital Pharmacies
CHAPTER 10. GLOBAL GENERIC PHARMACEUTICALS MARKET, REGIONAL ANALYSIS
10.1. Top Leading Countries
10.2. Top Emerging Countries
10.3. Generic Pharmaceuticals Market, Regional Market Snapshot
10.4. North America Generic Pharmaceuticals Market
10.4.1. U.S. Generic Pharmaceuticals Market
10.4.1.1. Type breakdown estimates & forecasts, 2020-2030
10.4.1.2. Application breakdown estimates & forecasts, 2020-2030
10.4.1.3. Product breakdown estimates & forecasts, 2020-2030
10.4.1.4. Route of Administration breakdown estimates & forecasts, 2020-2030 10.4.1.5. Distribution Channel breakdown estimates & forecasts, 2020-2030
10.4.2. Canada Generic Pharmaceuticals Market
10.5. Europe Generic Pharmaceuticals Market Snapshot
10.5.1. U.K. Generic Pharmaceuticals Market
10.5.2. Germany Generic Pharmaceuticals Market
10.5.3. France Generic Pharmaceuticals Market
10.5.4. Spain Generic Pharmaceuticals Market
10.5.5. Italy Generic Pharmaceuticals Market
10.5.6. Rest of Europe Generic Pharmaceuticals Market
10.6. Asia-Pacific Generic Pharmaceuticals Market Snapshot
10.6.1. China Generic Pharmaceuticals Market
10.6.2. India Generic Pharmaceuticals Market
10.6.3. Japan Generic Pharmaceuticals Market
10.6.4. Australia Generic Pharmaceuticals Market
10.6.5. South Korea Generic Pharmaceuticals Market
10.6.6. Rest of Asia Pacific Generic Pharmaceuticals Market
10.7. Latin America Generic Pharmaceuticals Market Snapshot
10.7.1. Brazil Generic Pharmaceuticals Market
10.7.2. Mexico Generic Pharmaceuticals Market
10.8. Rest of The World Generic Pharmaceuticals Market
CHAPTER 11. COMPETITIVE INTELLIGENCE
11.1. Key Company SWOT Analysis
11.1.1. Company
11.1.2. Company
11.1.3. Company
11.2. Top Market Strategies
11.3. Company Profiles
11.3.1. Teva Pharmaceutical Industries Ltd.
11.3.1.1. Key Information
11.3.1.2. Overview
11.3.1.3. Financial (Subject to Data Availability)
11.3.1.4. Product Summary
11.3.1.5. Recent Developments
11.3.2. Viatris Inc.
11.3.3. Novartis AG
11.3.4. Sun Pharmaceutical Industries Ltd.
11.3.5. LUPIN
11.3.6. AbbVie Inc. (Allergan)
11.3.7. AstraZeneca
11.3.8. Sawai Pharmaceutical Co., Ltd.
11.3.9. Hikma Pharmaceuticals PLC
11.3.10. Dr. Reddy’s Laboratories Ltd.
CHAPTER 12. RESEARCH PROCESS
12.1. Research Process
12.1.1. Data Mining
12.1.2. Analysis
12.1.3. Market Estimation
12.1.4. Validation
12.1.5. Publishing
12.2. Research Attributes
12.3. Research Assumption
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
1.2.1. Generic Pharmaceuticals Market, by Region, 2020-2030 (USD Billion)
1.2.2. Generic Pharmaceuticals Market, by Type, 2020-2030 (USD Billion)
1.2.3. Generic Pharmaceuticals Market, by Application, 2020-2030 (USD Billion)
1.2.4. Generic Pharmaceuticals Market, by Product, 2020-2030 (USD Billion)
1.2.5. Generic Pharmaceuticals Market, by Route of Administration, 2020-2030 (USD Billion)
1.2.6. Generic Pharmaceuticals Market, by Distribution Channel, 2020-2030 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
CHAPTER 2. GLOBAL GENERIC PHARMACEUTICALS MARKET DEFINITION AND SCOPE
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Industry Evolution
2.2.2. Scope of the Study
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
CHAPTER 3. GLOBAL GENERIC PHARMACEUTICALS MARKET DYNAMICS
3.1. Generic Pharmaceuticals Market Impact Analysis (2020-2030)
3.1.1. Market Drivers
3.1.1.1. Increasing ANDA approval and Generic Product Launches
3.1.1.2. Government initiatives to promote usage of generics
3.1.2. Market Challenges
3.1.2.1. High Cost of Generic Pharmaceuticals
3.1.2.2. Pricing issues
3.1.3. Market Opportunities
3.1.3.1. Increasing Disease Burden
3.1.3.2. Rising Geriatric Population
CHAPTER 4. GLOBAL GENERIC PHARMACEUTICALS MARKET INDUSTRY ANALYSIS
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Porter’s 5 Force Impact Analysis
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.3.5. Environmental
4.3.6. Legal
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. COVID-19 Impact Analysis
4.7. Disruptive Trends
4.8. Industry Expert Perspective
4.9. Analyst Recommendation & Conclusion
CHAPTER 5. GLOBAL GENERIC PHARMACEUTICALS MARKET, BY TYPE
5.1. Market Snapshot
5.2. Global Generic Pharmaceuticals Market by Type, Performance - Potential Analysis
5.3. Global Generic Pharmaceuticals Market Estimates & Forecasts by Type 2020-2030 (USD Billion)
5.4. Generic Pharmaceuticals Market, Sub Segment Analysis
5.4.1. Simple Generics
5.4.2. Specialty Generics
5.4.3. Biosimilars
CHAPTER 6. GLOBAL GENERIC PHARMACEUTICALS MARKET, BY APPLICATION
6.1. Market Snapshot
6.2. Global Generic Pharmaceuticals Market by Application, Performance - Potential Analysis
6.3. Global Generic Pharmaceuticals Market Estimates & Forecasts by Application 2020-2030 (USD Billion)
6.4. Generic Pharmaceuticals Market, Sub Segment Analysis
6.4.1. Central Nervous System Disorders
6.4.2. Respiratory Diseases
6.4.3. Hormones & Related Diseases
6.4.4. Gastrointestinal Diseases
6.4.5. Cardiovascular Diseases
6.4.6. Infectious Diseases
6.4.7. Others
CHAPTER 7. GLOBAL GENERIC PHARMACEUTICALS MARKET, BY PRODUCT
7.1. Market Snapshot
7.2. Global Generic Pharmaceuticals Market by Product, Performance - Potential Analysis
7.3. Global Generic Pharmaceuticals Market Estimates & Forecasts by Product 2020-2030 (USD Billion)
7.4. Generic Pharmaceuticals Market, Sub Segment Analysis
7.4.1. Small Molecule
7.4.2. Large Molecule
CHAPTER 8. GLOBAL GENERIC PHARMACEUTICALS MARKET, BY ROUTE OF ADMINISTRATION
8.1. Market Snapshot
8.2. Global Generic Pharmaceuticals Market by Route of Administration, Performance - Potential Analysis
8.3. Global Generic Pharmaceuticals Market Estimates & Forecasts by Route of Administration 2020-2030 (USD Billion)
8.4. Generic Pharmaceuticals Market, Sub Segment Analysis
8.4.1. Oral
8.4.2. Injectable
8.4.3. Inhalable
8.4.4. Others
CHAPTER 9. GLOBAL GENERIC PHARMACEUTICALS MARKET, BY DISTRIBUTION CHANNEL
9.1. Market Snapshot
9.2. Global Generic Pharmaceuticals Market by Distribution Channel, Performance - Potential Analysis
9.3. Global Generic Pharmaceuticals Market Estimates & Forecasts by Distribution channel 2020-2030 (USD Billion)
9.4. Generic Pharmaceuticals Market, Sub Segment Analysis
9.4.1. Online Pharmacies
9.4.2. Retail Pharmacies
9.4.3. Hospital Pharmacies
CHAPTER 10. GLOBAL GENERIC PHARMACEUTICALS MARKET, REGIONAL ANALYSIS
10.1. Top Leading Countries
10.2. Top Emerging Countries
10.3. Generic Pharmaceuticals Market, Regional Market Snapshot
10.4. North America Generic Pharmaceuticals Market
10.4.1. U.S. Generic Pharmaceuticals Market
10.4.1.1. Type breakdown estimates & forecasts, 2020-2030
10.4.1.2. Application breakdown estimates & forecasts, 2020-2030
10.4.1.3. Product breakdown estimates & forecasts, 2020-2030
10.4.1.4. Route of Administration breakdown estimates & forecasts, 2020-2030 10.4.1.5. Distribution Channel breakdown estimates & forecasts, 2020-2030
10.4.2. Canada Generic Pharmaceuticals Market
10.5. Europe Generic Pharmaceuticals Market Snapshot
10.5.1. U.K. Generic Pharmaceuticals Market
10.5.2. Germany Generic Pharmaceuticals Market
10.5.3. France Generic Pharmaceuticals Market
10.5.4. Spain Generic Pharmaceuticals Market
10.5.5. Italy Generic Pharmaceuticals Market
10.5.6. Rest of Europe Generic Pharmaceuticals Market
10.6. Asia-Pacific Generic Pharmaceuticals Market Snapshot
10.6.1. China Generic Pharmaceuticals Market
10.6.2. India Generic Pharmaceuticals Market
10.6.3. Japan Generic Pharmaceuticals Market
10.6.4. Australia Generic Pharmaceuticals Market
10.6.5. South Korea Generic Pharmaceuticals Market
10.6.6. Rest of Asia Pacific Generic Pharmaceuticals Market
10.7. Latin America Generic Pharmaceuticals Market Snapshot
10.7.1. Brazil Generic Pharmaceuticals Market
10.7.2. Mexico Generic Pharmaceuticals Market
10.8. Rest of The World Generic Pharmaceuticals Market
CHAPTER 11. COMPETITIVE INTELLIGENCE
11.1. Key Company SWOT Analysis
11.1.1. Company
11.1.2. Company
11.1.3. Company
11.2. Top Market Strategies
11.3. Company Profiles
11.3.1. Teva Pharmaceutical Industries Ltd.
11.3.1.1. Key Information
11.3.1.2. Overview
11.3.1.3. Financial (Subject to Data Availability)
11.3.1.4. Product Summary
11.3.1.5. Recent Developments
11.3.2. Viatris Inc.
11.3.3. Novartis AG
11.3.4. Sun Pharmaceutical Industries Ltd.
11.3.5. LUPIN
11.3.6. AbbVie Inc. (Allergan)
11.3.7. AstraZeneca
11.3.8. Sawai Pharmaceutical Co., Ltd.
11.3.9. Hikma Pharmaceuticals PLC
11.3.10. Dr. Reddy’s Laboratories Ltd.
CHAPTER 12. RESEARCH PROCESS
12.1. Research Process
12.1.1. Data Mining
12.1.2. Analysis
12.1.3. Market Estimation
12.1.4. Validation
12.1.5. Publishing
12.2. Research Attributes
12.3. Research Assumption
LIST OF TABLES
TABLE 1. Global Generic Pharmaceuticals Market, report scope
TABLE 2. Global Generic Pharmaceuticals Market estimates & forecasts by Region 2020-2030 (USD Billion)
TABLE 3. Global Generic Pharmaceuticals Market estimates & forecasts by Type 2020-2030 (USD Billion)
TABLE 4. Global Generic Pharmaceuticals Market estimates & forecasts by Application 2020-2030 (USD Billion)
TABLE 5. Global Generic Pharmaceuticals Market estimates & forecasts by Product 2020-2030 (USD Billion)
TABLE 6. Global Generic Pharmaceuticals Market estimates & forecasts by Route of Administration 2020-2030 (USD Billion)
TABLE 7. Global Generic Pharmaceuticals Market estimates & forecasts by Distribution Channel 2020-2030 (USD Billion)
TABLE 8. Global Generic Pharmaceuticals Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 9. Global Generic Pharmaceuticals Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 10. Global Generic Pharmaceuticals Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 11. Global Generic Pharmaceuticals Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 12. Global Generic Pharmaceuticals Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 13. Global Generic Pharmaceuticals Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 14. Global Generic Pharmaceuticals Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 15. Global Generic Pharmaceuticals Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 16. Global Generic Pharmaceuticals Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 17. Global Generic Pharmaceuticals Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 18. U.S. Generic Pharmaceuticals Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 19. U.S. Generic Pharmaceuticals Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 20. U.S. Generic Pharmaceuticals Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 21. Canada Generic Pharmaceuticals Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 22. Canada Generic Pharmaceuticals Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 23. Canada Generic Pharmaceuticals Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 24. UK Generic Pharmaceuticals Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 25. UK Generic Pharmaceuticals Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 26. UK Generic Pharmaceuticals Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 27. Germany Generic Pharmaceuticals Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 28. Germany Generic Pharmaceuticals Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 29. Germany Generic Pharmaceuticals Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 30. France Generic Pharmaceuticals Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 31. France Generic Pharmaceuticals Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 32. France Generic Pharmaceuticals Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 33. Italy Generic Pharmaceuticals Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 34. Italy Generic Pharmaceuticals Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 35. Italy Generic Pharmaceuticals Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 36. Spain Generic Pharmaceuticals Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 37. Spain Generic Pharmaceuticals Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 38. Spain Generic Pharmaceuticals Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 39. RoE Generic Pharmaceuticals Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 40. RoE Generic Pharmaceuticals Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 41. RoE Generic Pharmaceuticals Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 42. China Generic Pharmaceuticals Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 43. China Generic Pharmaceuticals Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 44. China Generic Pharmaceuticals Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 45. India Generic Pharmaceuticals Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 46. India Generic Pharmaceuticals Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 47. India Generic Pharmaceuticals Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 48. Japan Generic Pharmaceuticals Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 49. Japan Generic Pharmaceuticals Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 50. Japan Generic Pharmaceuticals Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 51. South Korea Generic Pharmaceuticals Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 52. South Korea Generic Pharmaceuticals Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 53. South Korea Generic Pharmaceuticals Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 54. Australia Generic Pharmaceuticals Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 55. Australia Generic Pharmaceuticals Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 56. Australia Generic Pharmaceuticals Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 57. RoAPAC Generic Pharmaceuticals Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 58. RoAPAC Generic Pharmaceuticals Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 59. RoAPAC Generic Pharmaceuticals Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 60. Brazil Generic Pharmaceuticals Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 61. Brazil Generic Pharmaceuticals Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 62. Brazil Generic Pharmaceuticals Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 63. Mexico Generic Pharmaceuticals Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 64. Mexico Generic Pharmaceuticals Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 65. Mexico Generic Pharmaceuticals Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 66. RoLA Generic Pharmaceuticals Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 67. RoLA Generic Pharmaceuticals Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 68. RoLA Generic Pharmaceuticals Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 69. Saudi Arabia Generic Pharmaceuticals Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 70. South Africa Generic Pharmaceuticals Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 71. RoMEA Generic Pharmaceuticals Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 72. List of secondary sources, used in the study of global Generic Pharmaceuticals Market
TABLE 73. List of primary sources, used in the study of global Generic Pharmaceuticals Market
TABLE 74. Years considered for the study
TABLE 75. Exchange rates considered
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
TABLE 1. Global Generic Pharmaceuticals Market, report scope
TABLE 2. Global Generic Pharmaceuticals Market estimates & forecasts by Region 2020-2030 (USD Billion)
TABLE 3. Global Generic Pharmaceuticals Market estimates & forecasts by Type 2020-2030 (USD Billion)
TABLE 4. Global Generic Pharmaceuticals Market estimates & forecasts by Application 2020-2030 (USD Billion)
TABLE 5. Global Generic Pharmaceuticals Market estimates & forecasts by Product 2020-2030 (USD Billion)
TABLE 6. Global Generic Pharmaceuticals Market estimates & forecasts by Route of Administration 2020-2030 (USD Billion)
TABLE 7. Global Generic Pharmaceuticals Market estimates & forecasts by Distribution Channel 2020-2030 (USD Billion)
TABLE 8. Global Generic Pharmaceuticals Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 9. Global Generic Pharmaceuticals Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 10. Global Generic Pharmaceuticals Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 11. Global Generic Pharmaceuticals Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 12. Global Generic Pharmaceuticals Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 13. Global Generic Pharmaceuticals Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 14. Global Generic Pharmaceuticals Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 15. Global Generic Pharmaceuticals Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 16. Global Generic Pharmaceuticals Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 17. Global Generic Pharmaceuticals Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 18. U.S. Generic Pharmaceuticals Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 19. U.S. Generic Pharmaceuticals Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 20. U.S. Generic Pharmaceuticals Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 21. Canada Generic Pharmaceuticals Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 22. Canada Generic Pharmaceuticals Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 23. Canada Generic Pharmaceuticals Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 24. UK Generic Pharmaceuticals Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 25. UK Generic Pharmaceuticals Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 26. UK Generic Pharmaceuticals Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 27. Germany Generic Pharmaceuticals Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 28. Germany Generic Pharmaceuticals Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 29. Germany Generic Pharmaceuticals Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 30. France Generic Pharmaceuticals Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 31. France Generic Pharmaceuticals Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 32. France Generic Pharmaceuticals Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 33. Italy Generic Pharmaceuticals Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 34. Italy Generic Pharmaceuticals Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 35. Italy Generic Pharmaceuticals Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 36. Spain Generic Pharmaceuticals Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 37. Spain Generic Pharmaceuticals Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 38. Spain Generic Pharmaceuticals Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 39. RoE Generic Pharmaceuticals Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 40. RoE Generic Pharmaceuticals Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 41. RoE Generic Pharmaceuticals Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 42. China Generic Pharmaceuticals Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 43. China Generic Pharmaceuticals Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 44. China Generic Pharmaceuticals Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 45. India Generic Pharmaceuticals Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 46. India Generic Pharmaceuticals Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 47. India Generic Pharmaceuticals Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 48. Japan Generic Pharmaceuticals Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 49. Japan Generic Pharmaceuticals Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 50. Japan Generic Pharmaceuticals Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 51. South Korea Generic Pharmaceuticals Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 52. South Korea Generic Pharmaceuticals Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 53. South Korea Generic Pharmaceuticals Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 54. Australia Generic Pharmaceuticals Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 55. Australia Generic Pharmaceuticals Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 56. Australia Generic Pharmaceuticals Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 57. RoAPAC Generic Pharmaceuticals Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 58. RoAPAC Generic Pharmaceuticals Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 59. RoAPAC Generic Pharmaceuticals Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 60. Brazil Generic Pharmaceuticals Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 61. Brazil Generic Pharmaceuticals Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 62. Brazil Generic Pharmaceuticals Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 63. Mexico Generic Pharmaceuticals Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 64. Mexico Generic Pharmaceuticals Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 65. Mexico Generic Pharmaceuticals Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 66. RoLA Generic Pharmaceuticals Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 67. RoLA Generic Pharmaceuticals Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 68. RoLA Generic Pharmaceuticals Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 69. Saudi Arabia Generic Pharmaceuticals Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 70. South Africa Generic Pharmaceuticals Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 71. RoMEA Generic Pharmaceuticals Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 72. List of secondary sources, used in the study of global Generic Pharmaceuticals Market
TABLE 73. List of primary sources, used in the study of global Generic Pharmaceuticals Market
TABLE 74. Years considered for the study
TABLE 75. Exchange rates considered
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
LIST OF FIGURES
FIG 1. Global Generic Pharmaceuticals Market, research methodology
FIG 2. Global Generic Pharmaceuticals Market, Market estimation techniques
FIG 3. Global Market size estimates & forecast methods
FIG 4. Global Generic Pharmaceuticals Market, key trends 2022
FIG 5. Global Generic Pharmaceuticals Market, growth prospects 2023-2030
FIG 6. Global Generic Pharmaceuticals Market, porters 5 force model
FIG 7. Global Generic Pharmaceuticals Market, pest analysis
FIG 8. Global Generic Pharmaceuticals Market, value chain analysis
FIG 9. Global Generic Pharmaceuticals Market by segment, 2020 & 2030 (USD Billion)
FIG 10. Global Generic Pharmaceuticals Market by segment, 2020 & 2030 (USD Billion)
FIG 11. Global Generic Pharmaceuticals Market by segment, 2020 & 2030 (USD Billion)
FIG 12. Global Generic Pharmaceuticals Market by segment, 2020 & 2030 (USD Billion)
FIG 13. Global Generic Pharmaceuticals Market by segment, 2020 & 2030 (USD Billion)
FIG 14. Global Generic Pharmaceuticals Market, regional snapshot 2020 & 2030
FIG 15. North America Generic Pharmaceuticals Market 2020 & 2030 (USD Billion)
FIG 16. Europe Generic Pharmaceuticals Market 2020 & 2030 (USD Billion)
FIG 17. Asia pacific Generic Pharmaceuticals Market 2020 & 2030 (USD Billion)
FIG 18. Latin America Generic Pharmaceuticals Market 2020 & 2030 (USD Billion)
FIG 19. Middle East & Africa Generic Pharmaceuticals Market 2020 & 2030 (USD Billion)
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
FIG 1. Global Generic Pharmaceuticals Market, research methodology
FIG 2. Global Generic Pharmaceuticals Market, Market estimation techniques
FIG 3. Global Market size estimates & forecast methods
FIG 4. Global Generic Pharmaceuticals Market, key trends 2022
FIG 5. Global Generic Pharmaceuticals Market, growth prospects 2023-2030
FIG 6. Global Generic Pharmaceuticals Market, porters 5 force model
FIG 7. Global Generic Pharmaceuticals Market, pest analysis
FIG 8. Global Generic Pharmaceuticals Market, value chain analysis
FIG 9. Global Generic Pharmaceuticals Market by segment, 2020 & 2030 (USD Billion)
FIG 10. Global Generic Pharmaceuticals Market by segment, 2020 & 2030 (USD Billion)
FIG 11. Global Generic Pharmaceuticals Market by segment, 2020 & 2030 (USD Billion)
FIG 12. Global Generic Pharmaceuticals Market by segment, 2020 & 2030 (USD Billion)
FIG 13. Global Generic Pharmaceuticals Market by segment, 2020 & 2030 (USD Billion)
FIG 14. Global Generic Pharmaceuticals Market, regional snapshot 2020 & 2030
FIG 15. North America Generic Pharmaceuticals Market 2020 & 2030 (USD Billion)
FIG 16. Europe Generic Pharmaceuticals Market 2020 & 2030 (USD Billion)
FIG 17. Asia pacific Generic Pharmaceuticals Market 2020 & 2030 (USD Billion)
FIG 18. Latin America Generic Pharmaceuticals Market 2020 & 2030 (USD Billion)
FIG 19. Middle East & Africa Generic Pharmaceuticals Market 2020 & 2030 (USD Billion)
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
